Skip to content
Sign in Cart LEPŠIA VEDA
SILNEJŠÍ TY
Regenerácia a výkon

HGH Frag 176-191 5 mg

Research compound · 5 mg vial

  • Lyophilised
  • Research use only
  • Third-party tested

The HGH Fragment 176-191 product is supplied as a 5 mg lyophilized powder in a sealed glass vial. Intended exclusively for laboratory research. It is not intended for human or veterinary use.

  • Laboratory researchDocumentation for the specific batch
  • Research standardsFocus on quality
  • Fast deliveryAcross the EU
  • Discreet packagingCarefully packed

52,50 €

The vial up close

HGH Frag 176-191 5 mg

Fragment hGH 176–191 · 5 mg. Lyophilised powder in a clear glass vial with a blue cap. Scroll to see it from every side.

01 · Purity

99% purity

The purity is printed right on the label. Every batch has a certificate of analysis (HPLC).

02 · Identity

CAS number

The substance’s unique registry number. It tells you exactly what is in the vial.

03 · Form

Lyophilised powder

The substance is freeze-dried into a fine powder. In this form it is more stable than in solution.

04 · Storage

2–8 °C after mixing

Keep the powder cool, dry and out of direct light. After mixing, store in the fridge at 2–8 °C.

05 · Batch

Batch and expiry

The batch number and expiry date are on every vial. Use the batch to find its certificate of analysis.

Product details
Contents per vial5 mg
FormLyophilized powder
PackagingSealed glass vial
Purity99 % (HPLC)
Storage2–8 °C, keep dry and protect from light
Molecular formulaC78H123N23O22S2
Molecular weight1799,10 g/mol
Sequence or structureFLRIVQCRSVEGSCGF; disulfide bridge Cys7–Cys14
CAS66004-57-7
Intended useFor laboratory research only

About this product

HGH Fragment 176-191 is a C-terminal fragment of human growth hormone studied mainly for its relationship to fat metabolism. Historical research has sought to separate the lipolytic effects of growth hormone from its growth and diabetogenic effects. Preclinical models therefore monitored fat breakdown, fat formation and body weight.

What is HGH Fragment 176-191?

HGH Fragment 176-191 is characterized in this portfolio as a synthetic peptide or peptide analog intended for controlled laboratory investigation. Scientific interest focuses on lipolysis, lipogenesis, body weight and fat mass, the separation of the metabolic effects of GH, and related biochemical or receptor processes.

Mechanism of action under investigation

The fragment corresponds to the part of the GH molecule associated in experimental models with lipid metabolism. It does not have the full receptor activity of intact growth hormone.

MAIN AREAS OF RESEARCH

•  Fat metabolism: Fragment 176-191 is derived from the C-terminal part of growth hormone and is being investigated for metabolic signals associated with adipose tissue.

•  Lipolysis: Preclinical research focuses on the mobilization of stored fats and the release of fatty acids from fat cells.

•  Lipogenesis: At the same time, it is monitored whether the fragment affects the process of formation and storage of new fat in adipocytes.

•  Fat mass: Animal models examine changes in fat mass and body weight.

Research findings to date

Work to date on HGH Fragment 176-191 has focused on areas including lipolysis, lipogenesis, body weight and fat mass, separating the metabolic effects of GH. Preclinical models therefore monitored fat breakdown, fat formation and body weight.

No reviews yet.
Bought this product? Be the first to review it.
Review with a photo and get 10 % off your next order. Without a photo: 5 %.
Laboratory researchDocumentation for the specific batch
Research standardsFocus on quality
Fast deliveryAcross the EU
Discreet packagingCarefully packed